Park Avenue Securities LLC Sells 750 Shares of Cognex Corporation $CGNX

Park Avenue Securities LLC lowered its holdings in shares of Cognex Corporation (NASDAQ:CGNX) by 6.9% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 10,118 shares of the scientific and technical instruments company’s stock after selling 750 shares during the period. Park Avenue Securities LLC’s holdings in Cognex were worth $321,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of CGNX. Geneos Wealth Management Inc. raised its stake in shares of Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after acquiring an additional 736 shares during the last quarter. Farther Finance Advisors LLC raised its stake in shares of Cognex by 439.4% during the first quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company’s stock valued at $29,000 after acquiring an additional 791 shares during the last quarter. GAMMA Investing LLC raised its stake in Cognex by 155.3% during the first quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company’s stock worth $32,000 after buying an additional 646 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in Cognex by 231.9% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company’s stock worth $34,000 after buying an additional 756 shares during the last quarter. Finally, UMB Bank n.a. raised its stake in Cognex by 105.5% during the first quarter. UMB Bank n.a. now owns 1,280 shares of the scientific and technical instruments company’s stock worth $38,000 after buying an additional 657 shares during the last quarter. Institutional investors own 88.12% of the company’s stock.

Cognex Stock Performance

Cognex stock opened at $45.30 on Wednesday. Cognex Corporation has a fifty-two week low of $22.67 and a fifty-two week high of $47.52. The stock has a market cap of $7.61 billion, a PE ratio of 63.80 and a beta of 1.50. The firm’s 50-day simple moving average is $42.65 and its 200 day simple moving average is $34.14.

Cognex (NASDAQ:CGNX) last released its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.02. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The business had revenue of $249.09 million for the quarter, compared to analysts’ expectations of $246.70 million. During the same period in the previous year, the company earned $0.23 earnings per share. The firm’s revenue for the quarter was up 4.2% compared to the same quarter last year. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. As a group, analysts predict that Cognex Corporation will post 0.61 EPS for the current fiscal year.

Cognex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Thursday, August 14th were issued a dividend of $0.08 per share. The ex-dividend date was Thursday, August 14th. This represents a $0.32 annualized dividend and a yield of 0.7%. Cognex’s payout ratio is 45.07%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. JPMorgan Chase & Co. began coverage on shares of Cognex in a research note on Monday, September 15th. They set a “neutral” rating and a $45.00 target price for the company. UBS Group lifted their price target on shares of Cognex from $53.00 to $58.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Citigroup reaffirmed a “neutral” rating and issued a $37.00 price target (up from $30.00) on shares of Cognex in a research note on Monday, July 14th. The Goldman Sachs Group lifted their price target on shares of Cognex from $36.00 to $40.00 and gave the company a “sell” rating in a research note on Tuesday, September 16th. Finally, Robert W. Baird lifted their price target on shares of Cognex from $30.00 to $32.00 and gave the company a “neutral” rating in a research note on Monday, June 16th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cognex presently has an average rating of “Moderate Buy” and a consensus price target of $43.07.

Insiders Place Their Bets

In related news, EVP Sheila Marie Dipalma sold 2,002 shares of the business’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $45.00, for a total transaction of $90,090.00. Following the transaction, the executive vice president directly owned 8,582 shares in the company, valued at approximately $386,190. The trade was a 18.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.60% of the company’s stock.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.